Shu-Jung Hsu
- Co-authors
- Zhenggang RenXiahui LinJiefeng CuiDongmei GaoRui ZhangWeifeng HongRongxin ChenShisuo Du
- Topics
- Cancer Immunotherapy and Biomarkers (6 papers)interferon and immune responses (4 papers)Hepatocellular Carcinoma Treatment and Prognosis (3 papers)
- Cited by
- HepatologyCancer ResearchOncology
- Partner nations
- ChinaEthiopiaUnited States
In The Last Decade
Shu-Jung Hsu
12 papers receiving 278 citations
Peers
Comparison fields: 5 of 57
- Molecular Biology 118
- Cancer Research 71
- Oncology 68
- Pulmonary and Respiratory Medicine 64
- Immunology 49
Countries citing papers authored by Shu-Jung Hsu
This map shows the geographic impact of Shu-Jung Hsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu-Jung Hsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu-Jung Hsu more than expected).
Fields of papers citing papers by Shu-Jung Hsu
This network shows the impact of papers produced by Shu-Jung Hsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu-Jung Hsu. The network helps show where Shu-Jung Hsu may publish in the future.
Co-authorship network of co-authors of Shu-Jung Hsu
This figure shows the co-authorship network connecting the top 25 collaborators of Shu-Jung Hsu. A scholar is included among the top collaborators of Shu-Jung Hsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu-Jung Hsu. Shu-Jung Hsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 5 | |
| 3 | 14 | |
| 4 | 4 | |
| 5 | 28 | |
| 6 | 27 | |
| 7 | 3 | |
| 8 | 63 | |
| 9 | 31 | |
| 10 | 1 | |
| 11 | 22 | |
| 12 | 21 | |
| 13 | 60 |
About Shu-Jung Hsu
Shu-Jung Hsu is a scholar working on Hepatology, Oncology and Immunology, having authored 13 papers that have together received 279 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), interferon and immune responses (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (3 papers). The work is most often cited by research in Hepatology (43 citations), Cancer Research (71 citations) and Oncology (68 citations). Shu-Jung Hsu has collaborated with scholars based in China, Ethiopia and United States. Frequent co-authors include Zhenggang Ren, Xiahui Lin, Jiefeng Cui, Dongmei Gao, Rui Zhang, Weifeng Hong, Rongxin Chen, Shisuo Du, Zhao‐Chong Zeng and Rongxin Chen. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Advanced Science and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.